Why is $CNTB stock down today?
Connect Biopharma Holdings Limited Ordinary Shares
Why is $CNTB down today?
The likely driver
Connect Biopharma Holdings Ltd: – Rademikibart meaningfully reduced the rate of treatment failure at 28 days by 66% compared to placebo –
SEC EDGAR·3:06 AM ET
- ›Rademikibart demonstrated a statistically significant increase from baseline in post-bronchodilator FEV1 on Day 7 of 250 mL compared to 120 mL with placebo (130mL greater improvement compared to placebo; p=0.023)
- ›Rademikibart reduced the treatment failure rate by approximately 66% over 28 days compared to placebo (p=0.153).
- ›50% reduction in emergency department visits or unscheduled medical visits for worsening asthma symptoms compared to placebo
The numbers behind the move
Short interest
4.1% of float
Days to cover
4.2d
Float
49.1M · Medium
Float rotation
0.2x
Dilution
Active
Insider buying
2 open-market
CNTB: active share dilution on file, 2 open-market insider buys.
Price
$1.10
Move today
-36.8%
Volume vs avg
0.0x
Scanner alerts today
16
Flagged in 30 days
144
Market cap
$109M
Prev close
$1.74
Avg volume
695K
Today’s scanner timeline
- 1:15 PMUnusual volume (RVOL) alert
- 1:14 PMBig % mover alert
- 12:47 PMBig % mover alert
- 12:47 PMUnusual volume (RVOL) alert
- 10:49 AMBig % mover alert
- 10:01 AMBig % mover alert
- 10:01 AMUnusual volume (RVOL) alert
- 9:57 AMUnusual volume (RVOL) alert
- 9:16 AMBig % mover alert
- 9:03 AMUnusual volume (RVOL) alert
- 8:26 AMBig % mover alert
- 8:13 AMBig % mover alert
Unusual-volume alerts often fire before the news is widely reported. This is when our scanner first flagged CNTB today.
Other stocks moving today
Each opens that stock’s own why-is-it-moving page.
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.